Europe Coagulation/Hemostasis Analyzer Market

Europe Coagulation/Hemostasis Analyzer Market Size

The coagulation/hemostasis analyzer market size in Europe was valued at USD 1.15 billion in 2023. The regional market is expected to be worth USD 1.26 billion in 2024 and USD 2.58 billion by 2032, exhibiting a CAGR of 9.4% from 2024 to 2032.

MARKET DRIVERS

The increased prevalence of cardiovascular illnesses and blood disorders, technological improvements in coagulation analyzers, and the growing elderly population drive the coagulation analyzers market in Europe. In addition, emerging economies and increasing reagent rental agreements are likely to provide growth prospects for market players in the following years. The rising prevalence of cardiovascular diseases and blood disorders increased the focus on medical device R&D and advanced healthcare technologies. In addition, rising expenditures on healthcare infrastructure development, particularly in developing economies, are the major factors driving the coagulation hemostasis analyzer market. Another vital consideration is that coagulation analyzers are medical equipment that quickly and efficiently measure blood platelet levels. Coagulation analyzers are used to prevent blood clots, which can cause heart attacks.

One of the primary reasons for the market's rise is Europe's increase in demand for laboratory automation. Another market growth determinant is a growing focus on technological developments in healthcare combined with an ever-increasing senior population. Increased attention to adopting technologies that improve the quality of life of patients suffering from thrombotic disorders and an increase in the number of hospitals and diagnostic centers will fuel market expansion.

MARKET RESTRAINTS

The lack of standards will stymie market expansion. The market would be further hampered by a lack of medical specialists and delayed implementation of these devices, particularly in developing and undeveloped economies. Furthermore, the high costs of fully automated coagulation analyzers would stifle market expansion. The government should implement policies in healthcare and provide better infrastructure.

REGIONAL ANALYSIS

Europe holds the second-largest share of the worldwide market. Germany accounted for the highest share of the European market in 2023 and is likely to continue its dominating role in the European market throughout the forecast period. The rising prevalence of lifestyle illnesses and blood disorders is propelling the coagulation analyzers market in the area. The UK market holds a prominent position in the European market over the forecast period owing to the changes in lifestyle and an increase in obese patients due to changes in eating habits in Europe. In addition, increased knowledge of diagnostic methods that can prevent heart attacks and an increase in the number of patients suffering from blood diseases are likely to drive regional hemostasis coagulation analyzer market growth.

KEY MARKET PLAYERS

Prominent Companies leading the European Coagulation/Hemostasis Analyzer Market Profiled in the Report are Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France), Helena Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), International Technidyne Corporation (U.S.), Instrumentation Laboratory (U.S.) and Siemens AG (Germany).,

MARKET SEGMENTATION

This research report on the European coagulation/hemostasis analyzer market is segmented and sub-segmented into the following categories.

By Test

• ACT
• APT
• D Dimer Testing
• Platelet Function Test
• Prothrombin Time Testing
• Anti-Factor Xa Test
• Heparin
• Protamine Dose-Response Test For ACT
• Fibrinogen Testing
• Other Coagulation Tests

By Product

• POC Testing Analyzers
• Clinical Laboratory Analyzers

By End User

• Clinical Laboratories
• PoC

By Technology

• Electrochemical
• Optical
• Mechanical

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe